Cargando…
Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
Autores principales: | Hughes, Jing, Vudattu, Nalini, Sznol, Mario, Gettinger, Scott, Kluger, Harriet, Lupsa, Beatrice, Herold, Kevan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370325/ https://www.ncbi.nlm.nih.gov/pubmed/25805871 http://dx.doi.org/10.2337/dc14-2349 |
Ejemplares similares
-
Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer
por: Dhodapkar, Kavita, et al.
Publicado: (2014) -
Two- and Four-Hour Tests Differ in Capture of C-Peptide Responses to a Mixed Meal in Type 1 Diabetes
por: Boyle, Karen D., et al.
Publicado: (2016) -
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors
por: Stamatouli, Angeliki M., et al.
Publicado: (2018) -
Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review
por: Heng, Jacob S, et al.
Publicado: (2022) -
Small Fiber Neuropathy in Patients With Latent Autoimmune Diabetes in Adults
por: Alam, Uazman, et al.
Publicado: (2015)